Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berthold

Showing results (211-220 of 6,943) with videos related to

Pageof 695
Sort By:
Hepato-Gastroenterology|August 3, 1999
Immunoglobulins and IgG subclasses in patients with inflammatory bowel diseaseI Gouni-Berthold, B Baumeister, H K Berthold, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 27, 2009
The stable isotope ketoisocaproic acid breath test as a measure of hepatic decarboxylation capacity: a quantitative analysis in normal subjects after oral and intravenous administrationHeiner K Berthold, Thomas A H Giesen, Ioanna Gouni-Berthold
Lipids|October 6, 1997
Failure of the nonselective beta-blocker propranolol to affect lipoprotein lipase gene expression in the ratI Gouni-Berthold, K Oka, H K Berthold, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|November 17, 2011
Lipid lowering in patients with chronic kidney disease: a SHARP turn in the wrong direction?Heiner K Berthold, Wilhelm Krone, Erland Erdmann, et al.
Plos One|September 22, 2011
Association between the interleukin-6 promoter polymorphism -174G/C and serum lipoprotein(a) concentrations in humansHeiner K Berthold, Matthias Laudes, Wilhelm Krone, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 12, 2010
Atherosclerotic disease location and disparities in the control and treatment of cardiovascular risk factors in patients with Type 2 diabetesH K Berthold, K P Bestehorn, W Krone, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|August 10, 2010
Lifibrol as a model compound for a novel lipid-lowering mechanism of actionHeiner K Berthold, Thomas Sudhop, Klaus von Bergmann, et al.
Pharmaceuticals (Basel, Switzerland)|July 27, 2024
Lipoprotein Metabolism, Dyslipidemia, and Lipid-Lowering Therapy in Women: A Comprehensive ReviewJakub Michal Zimodro, Magda Mucha, Heiner K Berthold, et al.
Plos One|April 2, 2013
Evidence from a randomized trial that simvastatin, but not ezetimibe, upregulates circulating PCSK9 levelsHeiner K Berthold, Nabil G Seidah, Suzanne Benjannet, et al.
European Journal of Biochemistry|December 11, 1976
Interaction of DNA with DNA-binding proteins. The characterization of protein HD from Escherichia coli and its nucleic acid complexesV Berthold, K Geider
Pageof 695

Showing results (211-220 of 6,943) with videos related to

Sort By:
Pageof 695
Hepato-Gastroenterology|August 3, 1999
Immunoglobulins and IgG subclasses in patients with inflammatory bowel diseaseI Gouni-Berthold, B Baumeister, H K Berthold, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 27, 2009
The stable isotope ketoisocaproic acid breath test as a measure of hepatic decarboxylation capacity: a quantitative analysis in normal subjects after oral and intravenous administrationHeiner K Berthold, Thomas A H Giesen, Ioanna Gouni-Berthold
Lipids|October 6, 1997
Failure of the nonselective beta-blocker propranolol to affect lipoprotein lipase gene expression in the ratI Gouni-Berthold, K Oka, H K Berthold, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|November 17, 2011
Lipid lowering in patients with chronic kidney disease: a SHARP turn in the wrong direction?Heiner K Berthold, Wilhelm Krone, Erland Erdmann, et al.
Plos One|September 22, 2011
Association between the interleukin-6 promoter polymorphism -174G/C and serum lipoprotein(a) concentrations in humansHeiner K Berthold, Matthias Laudes, Wilhelm Krone, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 12, 2010
Atherosclerotic disease location and disparities in the control and treatment of cardiovascular risk factors in patients with Type 2 diabetesH K Berthold, K P Bestehorn, W Krone, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|August 10, 2010
Lifibrol as a model compound for a novel lipid-lowering mechanism of actionHeiner K Berthold, Thomas Sudhop, Klaus von Bergmann, et al.
Pharmaceuticals (Basel, Switzerland)|July 27, 2024
Lipoprotein Metabolism, Dyslipidemia, and Lipid-Lowering Therapy in Women: A Comprehensive ReviewJakub Michal Zimodro, Magda Mucha, Heiner K Berthold, et al.
Plos One|April 2, 2013
Evidence from a randomized trial that simvastatin, but not ezetimibe, upregulates circulating PCSK9 levelsHeiner K Berthold, Nabil G Seidah, Suzanne Benjannet, et al.
European Journal of Biochemistry|December 11, 1976
Interaction of DNA with DNA-binding proteins. The characterization of protein HD from Escherichia coli and its nucleic acid complexesV Berthold, K Geider
Pageof 695